Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-16 · accession 0001104659-23-119962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-20 | 2023-11-16 | SUPN | NEWHALL CHARLES W III | Dir | M - OptEx | $9.24 | +7,457 | 119.6K | +7% | +$68.9K |
| D | 2023-11-20 | 2023-11-16 | SUPN | NEWHALL CHARLES W III | Dir | S - Sale+OE | $28.01 | -2,500 | 117.1K | -2% | -$70.0K |
| D | 2023-11-20 | 2023-11-16 | SUPN | NEWHALL CHARLES W III | Dir | M - OptEx | $0.00 | -7,457 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-16 | M | A | 7,457 | $9.24 | 119,589 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-16 | S | D | 2,500 | $28.01 | 117,089 | D | — | — | (F1) Represents the number of shares of common stock sold to cover the exercise price of the employee stock options. |
| 3 | Derivative | Director Stock Option (Right to Buy) | 2023-11-16 | M | D | 7,457 | $0.00 | 0 | D | $9.24 · 2015-01-21 to 2024-01-21 | 7,457 Common Stock |